TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Sustained Release Injectables
1.2 Key Market Segments
1.2.1 Sustained Release Injectables Segment by Type
1.2.2 Sustained Release Injectables Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Sustained Release Injectables Market Overview
2.1 Global Market Overview
2.1.1 Global Sustained Release Injectables Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Sustained Release Injectables Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Sustained Release Injectables Market Competitive Landscape
3.1 Global Sustained Release Injectables Sales by Manufacturers (2019-2024)
3.2 Global Sustained Release Injectables Revenue Market Share by Manufacturers (2019-2024)
3.3 Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Sustained Release Injectables Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Sustained Release Injectables Sales Sites, Area Served, Product Type
3.6 Sustained Release Injectables Market Competitive Situation and Trends
3.6.1 Sustained Release Injectables Market Concentration Rate
3.6.2 Global 5 and 10 Largest Sustained Release Injectables Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Sustained Release Injectables Industry Chain Analysis
4.1 Sustained Release Injectables Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Sustained Release Injectables Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Sustained Release Injectables Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sustained Release Injectables Sales Market Share by Type (2019-2024)
6.3 Global Sustained Release Injectables Market Size Market Share by Type (2019-2024)
6.4 Global Sustained Release Injectables Price by Type (2019-2024)
7 Sustained Release Injectables Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sustained Release Injectables Market Sales by Application (2019-2024)
7.3 Global Sustained Release Injectables Market Size (M USD) by Application (2019-2024)
7.4 Global Sustained Release Injectables Sales Growth Rate by Application (2019-2024)
8 Sustained Release Injectables Market Segmentation by Region
8.1 Global Sustained Release Injectables Sales by Region
8.1.1 Global Sustained Release Injectables Sales by Region
8.1.2 Global Sustained Release Injectables Sales Market Share by Region
8.2 North America
8.2.1 North America Sustained Release Injectables Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Sustained Release Injectables Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Sustained Release Injectables Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Sustained Release Injectables Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Sustained Release Injectables Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AntriaBio
9.1.1 AntriaBio Sustained Release Injectables Basic Information
9.1.2 AntriaBio Sustained Release Injectables Product Overview
9.1.3 AntriaBio Sustained Release Injectables Product Market Performance
9.1.4 AntriaBio Business Overview
9.1.5 AntriaBio Sustained Release Injectables SWOT Analysis
9.1.6 AntriaBio Recent Developments
9.2 Ascendis Pharma
9.2.1 Ascendis Pharma Sustained Release Injectables Basic Information
9.2.2 Ascendis Pharma Sustained Release Injectables Product Overview
9.2.3 Ascendis Pharma Sustained Release Injectables Product Market Performance
9.2.4 Ascendis Pharma Business Overview
9.2.5 Ascendis Pharma Sustained Release Injectables SWOT Analysis
9.2.6 Ascendis Pharma Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Sustained Release Injectables Basic Information
9.3.2 AstraZeneca Sustained Release Injectables Product Overview
9.3.3 AstraZeneca Sustained Release Injectables Product Market Performance
9.3.4 AstraZeneca Sustained Release Injectables SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Aurobindo
9.4.1 Aurobindo Sustained Release Injectables Basic Information
9.4.2 Aurobindo Sustained Release Injectables Product Overview
9.4.3 Aurobindo Sustained Release Injectables Product Market Performance
9.4.4 Aurobindo Business Overview
9.4.5 Aurobindo Recent Developments
9.5 Avadel
9.5.1 Avadel Sustained Release Injectables Basic Information
9.5.2 Avadel Sustained Release Injectables Product Overview
9.5.3 Avadel Sustained Release Injectables Product Market Performance
9.5.4 Avadel Business Overview
9.5.5 Avadel Recent Developments
9.6 Alkermes
9.6.1 Alkermes Sustained Release Injectables Basic Information
9.6.2 Alkermes Sustained Release Injectables Product Overview
9.6.3 Alkermes Sustained Release Injectables Product Market Performance
9.6.4 Alkermes Business Overview
9.6.5 Alkermes Recent Developments
9.7 Amylin Pharmaceuticals
9.7.1 Amylin Pharmaceuticals Sustained Release Injectables Basic Information
9.7.2 Amylin Pharmaceuticals Sustained Release Injectables Product Overview
9.7.3 Amylin Pharmaceuticals Sustained Release Injectables Product Market Performance
9.7.4 Amylin Pharmaceuticals Business Overview
9.7.5 Amylin Pharmaceuticals Recent Developments
9.8 Biomarin
9.8.1 Biomarin Sustained Release Injectables Basic Information
9.8.2 Biomarin Sustained Release Injectables Product Overview
9.8.3 Biomarin Sustained Release Injectables Product Market Performance
9.8.4 Biomarin Business Overview
9.8.5 Biomarin Recent Developments
9.9 Camurus
9.9.1 Camurus Sustained Release Injectables Basic Information
9.9.2 Camurus Sustained Release Injectables Product Overview
9.9.3 Camurus Sustained Release Injectables Product Market Performance
9.9.4 Camurus Business Overview
9.9.5 Camurus Recent Developments
9.10 Critical Pharmaceuticals
9.10.1 Critical Pharmaceuticals Sustained Release Injectables Basic Information
9.10.2 Critical Pharmaceuticals Sustained Release Injectables Product Overview
9.10.3 Critical Pharmaceuticals Sustained Release Injectables Product Market Performance
9.10.4 Critical Pharmaceuticals Business Overview
9.10.5 Critical Pharmaceuticals Recent Developments
9.11 Durect
9.11.1 Durect Sustained Release Injectables Basic Information
9.11.2 Durect Sustained Release Injectables Product Overview
9.11.3 Durect Sustained Release Injectables Product Market Performance
9.11.4 Durect Business Overview
9.11.5 Durect Recent Developments
9.12 Eli Lilly
9.12.1 Eli Lilly Sustained Release Injectables Basic Information
9.12.2 Eli Lilly Sustained Release Injectables Product Overview
9.12.3 Eli Lilly Sustained Release Injectables Product Market Performance
9.12.4 Eli Lilly Business Overview
9.12.5 Eli Lilly Recent Developments
9.13 Enzon
9.13.1 Enzon Sustained Release Injectables Basic Information
9.13.2 Enzon Sustained Release Injectables Product Overview
9.13.3 Enzon Sustained Release Injectables Product Market Performance
9.13.4 Enzon Business Overview
9.13.5 Enzon Recent Developments
9.14 Ipsen
9.14.1 Ipsen Sustained Release Injectables Basic Information
9.14.2 Ipsen Sustained Release Injectables Product Overview
9.14.3 Ipsen Sustained Release Injectables Product Market Performance
9.14.4 Ipsen Business Overview
9.14.5 Ipsen Recent Developments
9.15 InnoCore Pharmaceuticals
9.15.1 InnoCore Pharmaceuticals Sustained Release Injectables Basic Information
9.15.2 InnoCore Pharmaceuticals Sustained Release Injectables Product Overview
9.15.3 InnoCore Pharmaceuticals Sustained Release Injectables Product Market Performance
9.15.4 InnoCore Pharmaceuticals Business Overview
9.15.5 InnoCore Pharmaceuticals Recent Developments
9.16 Janssen
9.16.1 Janssen Sustained Release Injectables Basic Information
9.16.2 Janssen Sustained Release Injectables Product Overview
9.16.3 Janssen Sustained Release Injectables Product Market Performance
9.16.4 Janssen Business Overview
9.16.5 Janssen Recent Developments
9.17 Merck
9.17.1 Merck Sustained Release Injectables Basic Information
9.17.2 Merck Sustained Release Injectables Product Overview
9.17.3 Merck Sustained Release Injectables Product Market Performance
9.17.4 Merck Business Overview
9.17.5 Merck Recent Developments
9.18 NanOlogy
9.18.1 NanOlogy Sustained Release Injectables Basic Information
9.18.2 NanOlogy Sustained Release Injectables Product Overview
9.18.3 NanOlogy Sustained Release Injectables Product Market Performance
9.18.4 NanOlogy Business Overview
9.18.5 NanOlogy Recent Developments
9.19 Novartis
9.19.1 Novartis Sustained Release Injectables Basic Information
9.19.2 Novartis Sustained Release Injectables Product Overview
9.19.3 Novartis Sustained Release Injectables Product Market Performance
9.19.4 Novartis Business Overview
9.19.5 Novartis Recent Developments
9.20 Oakwood Laboratories/PharmaSophia
9.20.1 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Basic Information
9.20.2 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product Overview
9.20.3 Oakwood Laboratories/PharmaSophia Sustained Release Injectables Product Market Performance
9.20.4 Oakwood Laboratories/PharmaSophia Business Overview
9.20.5 Oakwood Laboratories/PharmaSophia Recent Developments
9.21 OctoPlus
9.21.1 OctoPlus Sustained Release Injectables Basic Information
9.21.2 OctoPlus Sustained Release Injectables Product Overview
9.21.3 OctoPlus Sustained Release Injectables Product Market Performance
9.21.4 OctoPlus Business Overview
9.21.5 OctoPlus Recent Developments
9.22 Pacira
9.22.1 Pacira Sustained Release Injectables Basic Information
9.22.2 Pacira Sustained Release Injectables Product Overview
9.22.3 Pacira Sustained Release Injectables Product Market Performance
9.22.4 Pacira Business Overview
9.22.5 Pacira Recent Developments
9.23 PhaseBio Pharmaceuticals
9.23.1 PhaseBio Pharmaceuticals Sustained Release Injectables Basic Information
9.23.2 PhaseBio Pharmaceuticals Sustained Release Injectables Product Overview
9.23.3 PhaseBio Pharmaceuticals Sustained Release Injectables Product Market Performance
9.23.4 PhaseBio Pharmaceuticals Business Overview
9.23.5 PhaseBio Pharmaceuticals Recent Developments
9.24 Recipharm AB
9.24.1 Recipharm AB Sustained Release Injectables Basic Information
9.24.2 Recipharm AB Sustained Release Injectables Product Overview
9.24.3 Recipharm AB Sustained Release Injectables Product Market Performance
9.24.4 Recipharm AB Business Overview
9.24.5 Recipharm AB Recent Developments
9.25 Roche
9.25.1 Roche Sustained Release Injectables Basic Information
9.25.2 Roche Sustained Release Injectables Product Overview
9.25.3 Roche Sustained Release Injectables Product Market Performance
9.25.4 Roche Business Overview
9.25.5 Roche Recent Developments
9.26 Sanofi
9.26.1 Sanofi Sustained Release Injectables Basic Information
9.26.2 Sanofi Sustained Release Injectables Product Overview
9.26.3 Sanofi Sustained Release Injectables Product Market Performance
9.26.4 Sanofi Business Overview
9.26.5 Sanofi Recent Developments
9.27 Taiwan Liposome Company (TLC)
9.27.1 Taiwan Liposome Company (TLC) Sustained Release Injectables Basic Information
9.27.2 Taiwan Liposome Company (TLC) Sustained Release Injectables Product Overview
9.27.3 Taiwan Liposome Company (TLC) Sustained Release Injectables Product Market Performance
9.27.4 Taiwan Liposome Company (TLC) Business Overview
9.27.5 Taiwan Liposome Company (TLC) Recent Developments
9.28 Xbrane Biopharma
9.28.1 Xbrane Biopharma Sustained Release Injectables Basic Information
9.28.2 Xbrane Biopharma Sustained Release Injectables Product Overview
9.28.3 Xbrane Biopharma Sustained Release Injectables Product Market Performance
9.28.4 Xbrane Biopharma Business Overview
9.28.5 Xbrane Biopharma Recent Developments
9.29 Livzon Pharm
9.29.1 Livzon Pharm Sustained Release Injectables Basic Information
9.29.2 Livzon Pharm Sustained Release Injectables Product Overview
9.29.3 Livzon Pharm Sustained Release Injectables Product Market Performance
9.29.4 Livzon Pharm Business Overview
9.29.5 Livzon Pharm Recent Developments
9.30 Luye Pharma Group
9.30.1 Luye Pharma Group Sustained Release Injectables Basic Information
9.30.2 Luye Pharma Group Sustained Release Injectables Product Overview
9.30.3 Luye Pharma Group Sustained Release Injectables Product Market Performance
9.30.4 Luye Pharma Group Business Overview
9.30.5 Luye Pharma Group Recent Developments
10 Sustained Release Injectables Market Forecast by Region
10.1 Global Sustained Release Injectables Market Size Forecast
10.2 Global Sustained Release Injectables Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Sustained Release Injectables Market Size Forecast by Country
10.2.3 Asia Pacific Sustained Release Injectables Market Size Forecast by Region
10.2.4 South America Sustained Release Injectables Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Sustained Release Injectables by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Sustained Release Injectables Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Sustained Release Injectables by Type (2025-2030)
11.1.2 Global Sustained Release Injectables Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Sustained Release Injectables by Type (2025-2030)
11.2 Global Sustained Release Injectables Market Forecast by Application (2025-2030)
11.2.1 Global Sustained Release Injectables Sales (Kilotons) Forecast by Application
11.2.2 Global Sustained Release Injectables Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings